We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$17.4B
AUM Growth
+$1.19B
Cap. Flow
+$1.49B
Cap. Flow %
8.58%
Top 10 Hldgs %
15.28%
Holding
2,331
New
178
Increased
1,214
Reduced
711
Closed
178

Sector Composition

Rank Sector Weight
1 Energy 10.07%
2 Healthcare 8.13%
3 Technology 7.73%
4 Financials 7.44%
5 Consumer Staples 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONY icon
2026
Sony
SONY
$138B
$297K ﹤0.01%
82,360
-2,850
-3% -$10.3K
AKS
2027
DELISTED
AK Steel Holding Corp
AKS
$296K ﹤0.01%
36,925
-1,533
-4% -$14.3K
AG icon
2028
First Majestic Silver
AG
$9.07B
$295K ﹤0.01%
37,800
-2,675
-7% -$26.5K
SJT
2029
San Juan Basin Royalty Trust
SJT
$118M
$294K ﹤0.01%
15,447
-25,211
-62% -$470K
SSNI
2030
DELISTED
Silver Spring Networks, Inc.
SSNI
$293K ﹤0.01%
30,373
-4,450
-13% -$48.4K
BRCM
2031
CALL
DELISTED
BROADCOM CORP CL-A
BRCM
$291K ﹤0.01%
28,000
-1,000
-3% -$38.9K
CQB
2032
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
$291K ﹤0.01%
+20,500
New +$251K
MFL
2033
DELISTED
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
$290K ﹤0.01%
20,895
RVBD
2034
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$290K ﹤0.01%
+15,662
New +$295K
BBK
2035
DELISTED
Blackrock Municipal Bond Trust
BBK
$290K ﹤0.01%
18,963
DNP icon
2036
DNP Select Income Fund
DNP
$4.09B
$288K ﹤0.01%
28,481
+2,576
+10% +$26.4K
FNHC
2037
DELISTED
FedNat Holding Company Common Stock
FNHC
$288K ﹤0.01%
+10,238
New +$242K
NPSP
2038
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$288K ﹤0.01%
+11,066
New +$318K
FRO icon
2039
Frontline
FRO
$8.85B
$286K ﹤0.01%
45,405
-300
-0.7% -$3.28K
XOOM
2040
DELISTED
XOOM CORP COM
XOOM
$286K ﹤0.01%
13,024
-63,823
-83% -$1.47M
HLT icon
2041
Hilton Worldwide
HLT
$71.5B
$283K ﹤0.01%
3,829
-1,487
-28% -$111K
SRPT icon
2042
Sarepta Therapeutics
SRPT
$1.77B
$283K ﹤0.01%
13,422
ECYT
2043
DELISTED
Endocyte, Inc. Common Stock
ECYT
$283K ﹤0.01%
+46,512
New +$318K
VISN
2044
Vistance Networks Inc
VISN
$2.52B
$282K ﹤0.01%
+11,800
New +$289K
CNTY icon
2045
Century Casinos
CNTY
$34M
$281K ﹤0.01%
54,750
+1,950
+4% +$10.5K
LNCE
2046
DELISTED
Snyders-Lance, Inc.
LNCE
$280K ﹤0.01%
+10,573
New +$284K
PGZ
2047
Principal Real Estate Income Fund
PGZ
$68.7M
$278K ﹤0.01%
14,600
+700
+5% +$13.5K
FUEL
2048
DELISTED
Rocket Fuel Inc.
FUEL
$278K ﹤0.01%
+17,625
New +$339K
ORBC
2049
DELISTED
ORBCOMM, Inc.
ORBC
$278K ﹤0.01%
48,400
-200
-0.4% -$1.25K
WSCI
2050
DELISTED
WSI Industries Inc
WSCI
$277K ﹤0.01%
37,901
-100
-0.3% -$767

Similar funds

Raymond James & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Raymond James & Associates held 2,331 positions worth $17.4B, up 7.3% from $16.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.49B of net new capital in Q3 2014, opening 178 new positions and adding to 1,214 existing holdings. Its largest new stake was Weatherford International plc: 1,504,232 shares worth $31.3M.

By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $22.6M trimmed.

  • Raymond James & Associates's largest Q3 2014 buy was Weatherford International plc: 1,504,232 shares worth $31.3M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2014, an estimated $48.8M increase.
  • Raymond James & Associates's biggest Q3 2014 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $22.6M.
  • Raymond James & Associates fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $26.5M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $17.4B portfolio in Q3 2014.
  • Raymond James & Associates opened 178 new positions and closed 178 in Q3 2014.
  • Raymond James & Associates's portfolio value rose 7.3% quarter-over-quarter to $17.4B.

Based on Raymond James & Associates's 13F filing for Q3 2014, filed 14 Nov 2014.